BEAM
Price
$26.75
Change
+$0.24 (+0.91%)
Updated
Aug 14 closing price
Capitalization
2.76B
85 days until earnings call
Intraday BUY SELL Signals
DTIL
Price
$7.43
Change
+$0.13 (+1.78%)
Updated
Aug 14 closing price
Capitalization
205.08M
86 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs DTIL

BEAM vs DTIL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BEAM vs. DTIL commentary
Aug 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and DTIL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2026
Stock price -- (BEAM: $26.75 vs. DTIL: $7.43)
Brand notoriety: BEAM and DTIL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 42% vs. DTIL: 26%
Market capitalization -- BEAM: $2.76B vs. DTIL: $205.08M
BEAM [@Biotechnology] is valued at $2.76B. DTIL’s [@Biotechnology] market capitalization is $205.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $128.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileDTIL’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • DTIL’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and DTIL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while DTIL’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 5 bearish.
  • DTIL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than DTIL.

Price Growth

BEAM (@Biotechnology) experienced а -2.66% price change this week, while DTIL (@Biotechnology) price change was -0.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.51%. For the same industry, the average monthly price growth was -1.43%, and the average quarterly price growth was +2992.28%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 09, 2026.

DTIL is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (+0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.76B) has a higher market cap than DTIL($205M). DTIL YTD gains are higher at: 78.606 vs. BEAM (-3.499). DTIL has higher annual earnings (EBITDA): -40.42M vs. BEAM (-349.25M). BEAM has more cash in the bank: 1.21B vs. DTIL (99.4M). DTIL has less debt than BEAM: DTIL (6.05M) vs BEAM (251M). BEAM has higher revenues than DTIL: BEAM (164M) vs DTIL (45.1M).
BEAMDTILBEAM / DTIL
Capitalization2.76B205M1,348%
EBITDA-349.25M-40.42M864%
Gain YTD-3.49978.606-4%
P/E RatioN/A4.53-
Revenue164M45.1M364%
Total Cash1.21B99.4M1,219%
Total Debt251M6.05M4,151%
FUNDAMENTALS RATINGS
BEAM vs DTIL: Fundamental Ratings
BEAM
DTIL
OUTLOOK RATING
1..100
5758
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9399
PRICE GROWTH RATING
1..100
5942
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BEAM's Valuation (25) in the null industry is in the same range as DTIL (56) in the Biotechnology industry. This means that BEAM’s stock grew similarly to DTIL’s over the last 12 months.

BEAM's Profit vs Risk Rating (100) in the null industry is in the same range as DTIL (100) in the Biotechnology industry. This means that BEAM’s stock grew similarly to DTIL’s over the last 12 months.

BEAM's SMR Rating (93) in the null industry is in the same range as DTIL (99) in the Biotechnology industry. This means that BEAM’s stock grew similarly to DTIL’s over the last 12 months.

DTIL's Price Growth Rating (42) in the Biotechnology industry is in the same range as BEAM (59) in the null industry. This means that DTIL’s stock grew similarly to BEAM’s over the last 12 months.

DTIL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BEAM (100) in the null industry. This means that DTIL’s stock grew similarly to BEAM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BEAMDTIL
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
72%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
DTIL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACWZX22.250.07
+0.32%
AMG GW&K Small/Mid Cap Growth Z
TILCX28.340.07
+0.25%
T. Rowe Price Lrg Cp Va I
JDEZX18.010.03
+0.17%
PGIM Jennison Global Equity Income Z
VGHRX58.47N/A
N/A
Voya Global High Dividend Low Vol R6
STFGX152.47-0.20
-0.13%
State Farm Growth

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.91%
CRSP - BEAM
75%
Closely correlated
-0.81%
PRME - BEAM
64%
Loosely correlated
-2.52%
EDIT - BEAM
62%
Loosely correlated
+0.36%
NTLA - BEAM
59%
Loosely correlated
+0.68%
AXON - BEAM
57%
Loosely correlated
-0.45%
More

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
+1.78%
AXON - DTIL
46%
Loosely correlated
-0.45%
EDIT - DTIL
44%
Loosely correlated
+0.36%
ORMP - DTIL
41%
Loosely correlated
+2.28%
ARRY - DTIL
39%
Loosely correlated
-2.32%
BEAM - DTIL
38%
Loosely correlated
+0.91%
More